EBITDA (ex-Noida3) grew 13.7 per cent y-o-y to Rs 2,804 with margins of 25.2 per cent compared to 25.3 per cent in Q2 FY25

Global Health, a multi-specialty tertiary care providers operating in the North and East regions of India, announced its audited consolidated financial results for the quarter ending September 30, 2025.

The company posted consolidated total income of Rs 11,189 million, compared to Rs 9,748 million in Q2 FY25; reflecting a growth of 14.8 per cent y-o-y. EBITDA (ex-Noida3) grew 13.7 per cent y-o-y to Rs 2,804 with margins of 25.2 per cent compared to 25.3 per cent in Q2 FY25. Including Noida, EBITDA was Rs 2,607 million, up 5.7 per cent y-o-y, with margins at 23.3 per cent. Medanta Noida generated Revenue of Rs 39 million and EBITDA loss of Rs 197 million. Profit After Tax was Rs 1,584 million, growth of 21.1 per cent y-o-y. PAT margins improved to 14.2 per cent from 13.4 per cent in Q2 FY25.

Matured hospitals revenue was Rs 7,200 million, growth of 5.4 per cent y-o-y. EBITDA was at Rs 1,696 million, growth of 0.4 per cent y-o-y. Developing hospitals ex Noida, the revenue was Rs 3,531 million, growth of 28.3 per cent y-o-y. EBITDA increased 34 per cent YoY to Rs 1,112 million, with margins improving to 31.5 per cent compared to 30.1 per cent in Q2 FY25. Including Noida, EBITDA stood at Rs 915 million, with margin of 25.6 per cent, reflecting the impact of initial ramp-up costs. International patients revenue increased by 48.5 per cent y-o-y to Rs 762 million in Q2 FY26, driven by increased international patient volume. OPD pharmacy (Hospital & Retail) continues to register strong double digit growth. Revenue increased by 23.9 per cent y-o-y to Rs 456 million in Q2 FY26.

Pankaj Sahni, Group CEO and Director said, "We are pleased to share that in September 2025, we launched our sixth hospital, a state-of-the-art, 550-bed facility in Noida. Over 150 doctors across key specialties have already joined the hospital, supported by the deployment of advanced medical technologies, they will be able to deliver world-class care in the region. We are encouraged by the initial response from the community and are progressively ramping up operations. During the quarter, the company delivered a strong performance, with revenue growth of 15 per cent year-on-year and 6 per cent sequential growth. EBITDA (excluding Noida) grew 14 per cent year-on-year and 10 per cent sequentially. Growth momentum remained broad-based across our network."